Living Cell Technologies Limited

Press Releases

2022-December-5	Appointment of Mr Madhukar Bhalla as Company Secretary (in PDF)
2022-November-24	Cessation of OptiCellAI Agreement (in PDF)
2022-November-4	Cancellation of Online Attendance Option for 2022 AGM (in PDF)
2022-November-1	2022 AGM Update - Withdrawal of Resolutions (in PDF)
2022-October-31	Board Changes (in PDF)
2022-October-28	Appendix 4C Quarterly Activities Report for the Quarter Ended 30 September 2022 (in PDF)
2022-October-27	Online Attendance Option for 2022 Annual General Meeting (in PDF)
2022-October-12	Chairman's Letter to Shareholders (in PDF)
2022-September-30	Notice of Annual General Meeting (in PDF)
2022-September-27	NEW 2022 Annual General Meeting Date (in PDF)
2022-September-19	2022 Annual General Meeting Date (in PDF)
2022-September-16	New Milestone as LCT and OptiCellAI Advance AI for NTCELL's Manufacture (in PDF)
2022-August-31	Preliminary Final Report for the Year Ended 30 June 2022 (in PDF)
2022-August-16	Choroid Plexus Tissue Shipped to Sydney as NTCELL Research Advances (in PDF)
2022-July-29	Appendix 4C Quarterly Activities Report for the Quarter Ended 30 June 2022 (in PDF)
2022-June-21	LCT Presenting at Gold Coast Investment Showcase (in PDF)
2022-June-3	Cleansing Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth) (in PDF)
2022-May-31	LCT Completes Strategic A$1.285M Placement in Boost for Parkinson's Disease Research (in PDF)
2022-May-23	Artificial Intelligence to Advance NTCELL Production; Agreement Signed with Sydney-Based Start-Up OptiCellAI (in PDF)
2022-April-29	Appendix 4C Quarterly Activities Report for the Quarter Ended 31 March 2022 (in PDF)
2022-April-28	Cleansing Notice Under Section 708AA(2)(f) of the Corporations Act 2001 (Cth) (in PDF)
2022-April-28	Chairman's Address Extraordinary General Meeting 28 April 2022 (in PDF)
2022-March-30	NTCELL to Be Produced in Australia for 1st Time under UTS Research Agreement (in PDF)
2022-March-25	General Meeting of Shareholders (in PDF)
2022-March-21	Funding Update-LCT Advancing NTCELL with Investor Backing (in PDF)
2022-March-04	Investor Webinar (in PDF)
2022-February-28	LCT Interim CEO's Term Extended as NTCELL Advances (in PDF)
2022-February-25	LCT Half Yearly Report Period Ended 31 December 2021 (in PDF)
2022-January-31	Appendix 4C Quarterly Activities Report for the Quarter Ended 31 December 2021 (in PDF)
2022-January-24	LCT Signs Service Agreement with NZeno, Secures Pig Cells for NTCELL® Trial (in PDF)
2023	2023 Press Releases
2021	2021 Press Releases
2020	2020 Press Releases
2019	2019 Press Releases
2018	2018 Press Releases
2017	2017 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases